概括
严重的高甘油三血症 (HTG) 构成急性胰腺炎的风险. 这一案例表明,稀释和离心有效地控制了脂质干扰,确保准确的实验室结果及时照顾患者.
科学领域:
- 临床化学 临床化学
- 实验室医学 实验室医学
- 关键的护理关键的护理
背景情况:
- 严重的高甘油三血症 (HTG) 是急性胰腺炎的重要危险因素.
- 实验室测试中的脂质干扰可以阻碍准确的诊断和延迟关键干预.
- 本案例报告涉及克服脂血症引起的分析错误的策略.
研究的目的:
- 要呈现一种严重的高甘油三血症 (HTG) 病例,具有显著的脂质干扰.
- 展示有效的方法来减轻由脂血病引起的实验室错误.
- 强调快速准确分析在管理高温气体方面的重要性.
主要方法:
- 一名患有严重高甘油三血症 (>21.94 mmol/L) 的患者出现了急性腹痛.
- 用10倍稀释进行快速脂质分析来管理脂质干扰.
- 使用高速离心 (15,000rpm,20分钟) 和潜伏物再处理进行了准确的分析.
主要成果:
- 通过稀释的初步脂质结果确定了极端高甘油三血 (77.72 mmol/L),导致迅速的血交换.
- 离心成功纠正电解质和蛋白质测量,确保可靠的结果.
- 通过准确的实验室数据来促进诊断和治疗干预.
结论:
- 稀释和离心是快速准确分析脂质样本的有效技术.
- 管理脂血的标准化方案对于及时的临床决策至关重要.
- 脂质干扰的有效管理改善了严重高甘油三血症病例患者的治疗结果.
相关概念视频
Lipid Digestion
98.5K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.5K
Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Chronic Pancreatitis II: Collaborative Care
291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
291
Acute Pancreatitis II: Clinical Manifestations and Management
705
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
705
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296


